Danaher Corporation vs Ford Motor Company — how do they compare? Danaher Corporation trades at $220.03 (market cap $152.87B), while Ford Motor Company trades at $12.19 (market cap $48.85B). The key difference: Danaher Corporation is far larger — about 3.1× Ford Motor Company's market cap, and Ford Motor Company pays the higher dividend (4.9%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Ford Motor Company for 105 Days on average.
| DHR | F | |
|---|---|---|
Market Cap | $152.87B | $48.85B |
Volume | 5,228,698 | 57,748,965 |
Sector | Health | Consumer Cyclical |
52-Week High | $242.05 | $17.44 |
52-Week Low | $161.91 | $11.21 |
Typical Hold Time | 69 Days | 105 Days |
Enterprise Value | $175.08B | $180.81B |
Dividend Yield | 0.74% | 4.9% |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
Ford Motor Company (F) trades at $12.23, up 0.87% with a mixed technical picture showing bearish moving averages but neutral oscillators. Fundamentally, the company reported a net loss of $8.18 billion in 2025 despite $187.27 billion revenue, with negative profit margins and high debt levels. Recent news highlights a 6.6% Q3 sales decline and supplier disruptions affecting F-150 production, though the company maintains its No. 3 U.S. sales position.
The outlook remains challenging with persistent losses and competitive pressures, though analyst consensus suggests 30% upside to the $15.90 price target. Key risks include ongoing operational issues, high leverage, and market share erosion to Asian rivals. Investment appeal hinges on execution improvements and hybrid vehicle transition success.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →